Lattuada E, Lanzafame M, Grosso C, Soldani, et al. F. Optimal fosamprenavir regimen to prevent lipid abnormalities. Acta Biomed [Internet]. 2009 Dec. 1 [cited 2024 Jul. 27];80(3):200-2. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1171